LymeAid

LymeAid is a biotechnology company focused on improving the detection and diagnosis of Lyme disease through innovative rapid testing solutions. The company's flagship product is a rapid diagnostic test designed to provide quick and accurate results, addressing the limitations of traditional laboratory-based testing which often suffers from long turnaround times and low sensitivity in early stages. By utilizing lateral flow assay technology, LymeAid aims to empower healthcare providers and patients with immediate diagnostic information to facilitate early treatment. The company operates at the intersection of medical diagnostics and infectious disease management, targeting a significant unmet need in regions where Lyme disease is endemic.